The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A retrospective analysis

OBJECTIVE: Sulfonylureas have historically been analyzed as a medication class, which may be inappropriate given the differences in properties inherent to the individual sulfonylureas (hypoglycemic risk, sulfonylurea receptor selectivity, and effects on myocardial ischemic preconditioning). The purp...

Descripción completa

Detalles Bibliográficos
Autores principales: Pantalone, Kevin M., Kattan, Michael W., Yu, Changhong, Wells, Brian J., Arrigain, Susana, Jain, Anil, Atreja, Ashish, Zimmerman, Robert S.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875427/
https://www.ncbi.nlm.nih.gov/pubmed/20215447
http://dx.doi.org/10.2337/dc10-0017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875427/
https://www.ncbi.nlm.nih.gov/pubmed/20215447
http://dx.doi.org/10.2337/dc10-0017

Ejemplares similares